These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4267735)

  • 41. [Hemostasis disturbances in premature infants with respiratory distress. Influence of the severity of the distress].
    Jensen AH; Couchard M; Relier JP; Zamet P; Muller P
    Ann Pediatr (Paris); 1976 Oct; 23(10):605-10. PubMed ID: 16106887
    [No Abstract]   [Full Text] [Related]  

  • 42. Differentiation of fibrinogen degradation products (FDP) in plasma by precipitation with polyethylene glycol.
    Zubler RH; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1974 Sep; 104(39):1367-8. PubMed ID: 4213874
    [No Abstract]   [Full Text] [Related]  

  • 43. Causes of a negative ethanol gelation test in diffuse intravascular coagulation.
    Gerrits WB; Prakke EM; van der Meer J; Vreeken J
    Thromb Diath Haemorrh; 1974 May; 31(2):299-308. PubMed ID: 4277392
    [No Abstract]   [Full Text] [Related]  

  • 44. [Value of the use of glutaraldehyde for the sensitization of red cells in Merskey's technic].
    Quichaud C; de Cacqueray-Joigny C; Etcharry F; Moras M; Chatelan M; Boisseau M; Bentegeat J
    Pathol Biol (Paris); 1974 Nov; 22 suppl():92-6. PubMed ID: 4219981
    [No Abstract]   [Full Text] [Related]  

  • 45. [Changes in clotting mechanism in consumption coagulopathy].
    Maekawa T; Suzuki Y; Kobayashi N; Ito T
    Rinsho Ketsueki; 1972 Apr; 13(2):167-76. PubMed ID: 4674796
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative effects of proteinase inhibitors, plasminogen antiactivators, heparin and acetylsalicylic acid on the experimental disseminated intravascular coagulation induced by thormbin.
    Moriau M; Rodhain J; Noel H; Beys-Col CD; Masure R
    Thromb Diath Haemorrh; 1974 Sep; 32(1):171-88. PubMed ID: 4281540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Degradation products of fibrinogen in connective tissue disorders: probable relation to the presence of microangiopathies].
    Alarcon-Segovia D; Fishbein E; Zavala Mejía JL
    Rev Invest Clin; 1971; 23(1):43-7. PubMed ID: 4397967
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
    Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Consumption coagulopathy observed mainly in obstetrics].
    Masaki M
    Rinsho Ketsueki; 1972 Apr; 13(2):195-7. PubMed ID: 4674797
    [No Abstract]   [Full Text] [Related]  

  • 50. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs.
    Feldman BF; Madewell BR; O'Neill S
    J Am Vet Med Assoc; 1981 Jul; 179(2):151-4. PubMed ID: 7263467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of fibrinogen in cirrhosis of the liver.
    Tytgat GN; Collen D; Verstraete M
    South Med J; 1971 Oct; 64(10):1690-701. PubMed ID: 5125556
    [No Abstract]   [Full Text] [Related]  

  • 52. Study of the defibrination syndrome associated with acute hepatic failure.
    Tan BH; Mori K; Richter D; Quinlan R; Gans H
    Surg Gynecol Obstet; 1971 Feb; 132(2):263-74. PubMed ID: 4993879
    [No Abstract]   [Full Text] [Related]  

  • 53. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metabolism of fibrinogen in the cirrhotic patient. Dynamic study by isotope method].
    Delmont J; Bisset J; Rampal P; Camous JP; Faure X
    Nouv Presse Med; 1976 Jun; 5(25):1567-9. PubMed ID: 934880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage.
    Marder VJ; Shulman NR; Carroll WR
    Trans Assoc Am Physicians; 1967; 80():156-67. PubMed ID: 4230117
    [No Abstract]   [Full Text] [Related]  

  • 57. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

  • 58. The pathobiochemistry of DIC.
    Gaffney PJ
    Haematologica; 1980 Oct; 65(5):612-25. PubMed ID: 6450719
    [No Abstract]   [Full Text] [Related]  

  • 59. Occurrence of soluble very high molecular weight fibrinogen complexes in hypercoagulable states. An in vitro and in vivo study on their features.
    Neri Serneri GG; Gensini GF; Abbate R; Favilla S
    Thromb Haemost; 1980 Feb; 42(5):1561-73. PubMed ID: 6768154
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M; Arnesen H; Godal HC
    Thromb Diath Haemorrh; 1973 Jun; 29(3):592-7. PubMed ID: 4271546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.